Blade Air Mobility第二季度业绩喜忧参半

2025-08-05 19:15

Blade Air Mobility press release (NASDAQ:BLDE): Q2 GAAP EPS of -$0.05 misses by $0.01.
Revenue of $70.8M (+4.2% Y/Y) beats by $6.72M.
Medical revenue increased 17.6% year-over-year in Q2 2025
Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025⁽¹⁾
Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade’s Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata")
Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis

More on Blade Air Mobility